Gene Therapy products continue to advance as unique therapeutic tools, offering potential cures to several genetic diseases for which there are no or limited treatment options.
Regulatory guidance on gene therapy products evolves at the same time, supporting the developers in their journey from early research phase to pivotal clinical studies, and eventually marketing authorization.